Prognostic significance of serum inflammation indices for different tumor infiltrative pattern types of gastric cancer

Figure 6 Nomogram models predicting the survival of patients with different tumor infiltrative pattern types. A, D and G: Nomogram models predicting the 3-year and 5-year survival of patients with the expansive growth type (INFa), the intermediate type (INFb), and the infiltrative growth type (INFc) gastric cancer (GC); B and C: Receiver operating characteristic (ROC) of the nomogram model and postsurgical tumor node metastasis (pTNM) stage predicting the 3-year and 5-year survival of patients with INFa GC; E and F: ROC of the nomogram model and pTNM stage predicting the 3-year and 5-year survival of patients with INFb GC; H and I: ROC curve of the nomogram model and pTNM stage predicting the 3-year and 5-year survival of patients with INFc GC. INFa: The expansive growth type; INFb: The intermediate type; INFc: The infiltrative growth type; ROC: Receiver operating characteristic curve; mLNR: Metastatic lymph node ratio; BMI: Body mass index; PLR: Platelet-lymphocyte ratio; SII: Systemic immune-inflammation index.